Published in J Neurooncol on December 12, 2007
Thalamic deep brain stimulation for neuropathic pain after amputation or brachial plexus avulsion. Neurosurg Focus (2013) 1.45
Suicide attempts after subthalamic nucleus stimulation for Parkinson's disease. Eur Neurol (2010) 1.40
Second-Line Chemotherapy in Recurrent Glioblastoma: A 2-Cohort Study. Oncol Res Treat (2015) 1.39
Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Int J Surg Pathol (2005) 1.00
Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study. Oncol Rep (2010) 0.99
BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas. Virchows Arch (2004) 0.95
Prognostic biomarkers in thyroid cancer. Virchows Arch (2014) 0.95
Poorly differentiated carcinomas of the thyroid gland: a review of the clinicopathologic features of a series of 28 cases of a heterogeneous, clinically aggressive group of thyroid tumors. Int J Surg Pathol (2002) 0.92
Molecular pathology of well-differentiated thyroid carcinomas. Virchows Arch (2005) 0.90
Impact of EGFR genetic variants on glioma risk and patient outcome. Cancer Epidemiol Biomarkers Prev (2011) 0.86
Follicular, papillary, and "hybrid" carcinomas of the thyroid. Endocr Pathol (2002) 0.83
Splenomegaly, hypersplenism and peripheral blood cytopaenias in patients with classical Anderson-Fabry disease. Virchows Arch (2008) 0.82
Acquisition of BRAF gene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2008) 0.81
Gastroduodenal Burkitt´s lymphoma in an immunocompetent patient. Rev Esp Enferm Dig (2013) 0.79
Impact of TGF-β1 -509C/T and 869T/C polymorphisms on glioma risk and patient prognosis. Tumour Biol (2015) 0.78
Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson's Disease in a Patient with HIV Infection: Dual Clinical Benefit. Case Rep Neurol (2011) 0.76
Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex. Virchows Arch (2002) 0.76
Role of Tc-Sulesomab Immunoscintigraphy in the Management of Infection following Deep Brain Stimulation Surgery. Neurol Res Int (2011) 0.75
Hemophagocytic Syndrome Associated with Hodgkin's Lymphoma First Presenting as Fever and Pancytopenia. Case Rep Med (2010) 0.75
Deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease: five year follow-up at a Portuguese center. Rev Neurol (2014) 0.75
Intracerebral abscess: a rare complication of Deep Brain Stimulation. Neurocirugia (Astur) (2012) 0.75
Vascular invasion in thyroid and gastric carcinomas. Ultrastruct Pathol (2003) 0.75
Cutaneous lesions as the first manifestation of systemic follicular lymphoma in an HIV patient. Dermatol Online J (2008) 0.75
[Imaging in Parkinson disease surgery]. Acta Med Port (2003) 0.75
MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism. Eur J Endocrinol (2012) 0.75
Coexistence of Kaposi sarcoma and gastric diffuse large B-cell lymphoma in a HIV-infected patient. Rev Esp Enferm Dig (2015) 0.75
Indolent systemic mastocytosis limited to the bone: a case report and review of the literature. Sao Paulo Med J (2013) 0.75